CollPlant Biotechnologies Ltd Ordinary Shares (CLGN) is a publicly traded Healthcare sector company. As of May 21, 2026, CLGN trades at $0.45 with a market cap of $6.27M and a P/E ratio of 0.00. CLGN moved +0.00% today. Year to date, CLGN is -68.75%; over the trailing twelve months it is -77.27%. Its 52-week range spans $0.27 to $5.00. Rallies surfaces CLGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own CLGN include Citadel Advisors. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for CollPlant Biotechnologies Ltd Ordinary Shares.
| Metric | Value |
|---|---|
| Price | $0.45 |
| Market Cap | $6.27M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.00 |
| 52-Week Low | $0.27 |
| Volume | 11.80K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
CLGN analyst coverage data. Average price target: $0.00.